Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy and safety of lenvatinib and pembrolizumab in combination with TACE versus TACE plus oral and intravenous (IV) placebos in participants with incur...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merck Sharp & Dohme LLC
Collaborators
NCT06687941 · Neoplasms, Carcinoma, Hepatocellular, and more
NCT06571396 · Carcinoma, Hepatocellular, Immunotherapy
NCT06454578 · Carcinoma, Hepatocellular
NCT05870969 · Carcinoma, Hepatocellular, Hepatitis C, Chronic, and more
NCT02221778 · Carcinoma, Hepatocellular
Arizona Oncology Associates PC- HOPE ( Site 0770)
Tucson, Arizona
Scripps Clinic Torrey Pines ( Site 0714)
La Jolla, California
USC Norris Comprehensive Cancer Center ( Site 0717)
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions